Gynecologic Oncology


Every year, almost 400,000 new instances of cervical cancer are diagnosed throughout the world. In the United States, there were 12,820 new cases expected in 2017, with around 4,210 fatalities. At all Gynecologic Oncology Conferences and other Gynecology Meetings, the topic Gynecologic Oncology is the most talked keytopic. Abnormal vaginal bleeding is the most prevalent sign of cervical cancer, including postcoital and intermenstrual bleeding, menorrhagia, and postmenopausal haemorrhage. Pelvic fullness/pain, unilateral leg edoema, bladder irritation, and tenesmus are some of the other symptoms. Cervical cancer is frequently asymptomatic, with symptoms appearing until after a negative Pap screening, a colposcopy check, or a cervical biopsy.



 


    Related Conference of Gynecologic Oncology

    March 27-28, 2024

    6th International Conference on Digital Health

    London, UK
    April 24-25, 2024

    35th European Heart and Heart Failure Congress

    Paris, France
    June 21-22, 2024

    52nd Global Nursing & Healthcare Conference

    Rome, Italy
    September 09-10, 2024

    3rd Global Summit on Physiology and Metabolism of Thyroid

    Paris, France
    September 18-19, 2024

    29th International Conference on Skincare and Cosmetology

    Amsterdam, Netherlands
    September 19-20, 2024

    20th Global Biomarkers and Clinical Research Summit

    Amsterdam, Netherlands
    September 24-25, 2024

    5th Global Summit on Public Health

    Paris, France

    Gynecologic Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in